Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial-Reference-Cited by-同舟云学术

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

Published:2016-12-30 Issue:7 Volume:76 Page:1219-1227
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Coghlan John Gerry,Galiè Nazzareno,Barberà Joan Albert,Frost Adaani E,Ghofrani Hossein-Ardeschir,Hoeper Marius M,Kuwana Masataka,McLaughlin Vallerie V,Peacock Andrew J,Simonneau Gérald,Vachiéry Jean-Luc,Blair Christiana,Gillies Hunter,Miller Karen L,Harris Julia H N,Langley Jonathan,Rubin Lewis J

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference21 articles.

1. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease;Oudiz;Chest,2004

2. Bosentan therapy for pulmonary arterial hypertension;Rubin;N Engl J Med,2002

3. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease;Badesch;J Rheumatol,2007

4. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions;Denton;Ann Rheum Dis,2006

5. Beraprost therapy for pulmonary arterial hypertension;Barst;J Am Coll Cardiol,2003

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tocilizumab plus Nintedanib for progressive interstitial lung disease in systemic sclerosis: a one-year observational study;Rheumatology International;2024-08-24

2. Pulmonary Hypertension Associated with Connective Tissue Disease;Rheumatic Disease Clinics of North America;2024-08

3. Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH‐CTD): Real‐world experience from EXPOSURE;Pulmonary Circulation;2024-07

4. Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data;Autoimmunity Reviews;2024-04

5. Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis;Seminars in Respiratory and Critical Care Medicine;2024-03-18